A review of Ramadan fasting and regular physical activity on metabolic syndrome indices

During Ramadan, patients change the timing and doses of their medicine. They take the medicine at )ftar breakfast time and/or at Sahor pre-dawn meal time. A drop in

Our results suggested that Ramadan fasting had no adverse effects on inflammatory markers of cardiovascular risk factors and might improve BMI, body fat mass, and trunk

In a study in this regard, plasma levels of FFAs were compared between two groups of obese and overweight NAFLD patients, and the saturated fatty acids were

According to the results, fasting during Ramadan is a good opportunity for patients and healthy subjects for control and prevent from diabetes, hypertension,

In conclusion, Ramadan fasting, as a diet intervention can positively modulate cardiovascular risks in patients by decreasing the levels of SAA as a biomarker of inflammation

Based on this background, in the present study we aimed to examine the associations of FPG and impaired fasting glucose (IFG) and diabetes risk with the urinary levels of 23

Intermittent fasting during Ramadan can cause adiponectin elevation in men have risk factors of diabetes type 2 and may be of help to decrease risk of type- 2 diabetes.. Further

Moreover, the annual period of fasting has no long-term effects on cardiovascular risks (30), these studies suffer from several confounding factors including restricted sample